Abstract
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Current Signal Transduction Therapy
Title:Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM)
Volume: 16 Issue: 2
Author(s): Nastaran Shahparian, Mehran Yazdi*Mohammad Reza Khosravi
Affiliation:
- School of Electrical and Computer Engineering, Shiraz University,Iran
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Abstract:
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Export Options
About this article
Cite this article as:
Shahparian Nastaran, Yazdi Mehran *, Khosravi Reza Mohammad , Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM), Current Signal Transduction Therapy 2021; 16 (2) . https://dx.doi.org/10.2174/1574362414666191202144116
DOI https://dx.doi.org/10.2174/1574362414666191202144116 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
On the Physiological Relevance of Muscarinic Acetylcholine Receptors in Alzheimers Disease
Current Medicinal Chemistry Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Mini-Reviews in Medicinal Chemistry Classifying Cognitive Normal and Early Mild Cognitive Impairment of Alzheimer’s Disease by Applying Restricted Boltzmann Machine to fMRI Data
Current Bioinformatics Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections
Current Topics in Medicinal Chemistry Therapeutic Use of Snake Venom Components: A Voyage from Ancient to Modern India
Mini-Reviews in Organic Chemistry Sibutramine Effects on Central Mechanisms Regulating Energy Homeostasis
Current Neuropharmacology Body Dysmorphic Disorder: A Review of Current Nosological Issues and Associated Cognitive Deficits
Current Psychiatry Reviews The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
Current Pediatric Reviews Running Exercise Reduces Myelinated Fiber Loss in the Dentate Gyrus of the Hippocampus in APP/PS1 Transgenic Mice
Current Alzheimer Research Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways
Current Neuropharmacology Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication
Current Alzheimer Research Caspase-3 Short Hairpin RNAs: A Potential Therapeutic Agent in Neurodegeneration of Aluminum-Exposed Animal Model
Current Alzheimer Research Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design An Overview of Pharmacogenetics in Psychotropic Drugs
Current Psychiatry Reviews A Dual Mechanism Linking NGF/proNGF Imbalance and Early Inflammation to Alzheimer's Disease Neurodegeneration in the AD11 Anti-NGF Mouse Model
CNS & Neurological Disorders - Drug Targets Stem Cells in MDR-TB and XDR - TB
Current Respiratory Medicine Reviews Compatible Solute Engineering in Plants for Abiotic Stress Tolerance - Role of Glycine Betaine
Current Genomics Graphical Abstracts
Current Nanoscience The Hydrogen Peroxide and its Importance in Alzheimers and Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents